Humacyte Inc (HUMA) — Cash Flow-to-Debt Ratio
Latest as of December 2025:
-0.23x
Humacyte Inc (HUMA) has a Cash Flow-to-Debt Ratio of -0.23x as of December 2025, meaning its operating cash flow of $-26.12 Million could theoretically repay 0% of its total liabilities ($113.26 Million) in one year. Explore HUMA long-term investments to assets to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
-0.23x
Operating CF / Total Liabilities
Operating Cash Flow
$-26.12 Million
USD
Total Liabilities
$113.26 Million
USD
Data as of
Dec 2025
Most recent filing
Humacyte Inc Cash Flow-to-Debt Ratio (2019–2025)
Historical debt coverage capacity for Humacyte Inc across 7 annual periods. Also explore HUMA total asset value for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Humacyte Inc (2019–2025)
Year-by-year debt coverage analysis for Humacyte Inc. For market capitalisation and broader financial context, see market cap of Humacyte Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.93x | $-105.04 Million | $113.26 Million | ▼ -80.1% |
| 2024 | -0.51x | $-98.12 Million | $190.54 Million | ▲ +19.4% |
| 2023 | -0.64x | $-73.31 Million | $114.68 Million | ▲ +21.5% |
| 2022 | -0.81x | $-71.13 Million | $87.37 Million | ▼ -64.8% |
| 2021 | -0.49x | $-81.19 Million | $164.36 Million | ▲ +68.0% |
| 2020 | -1.54x | $-55.57 Million | $36.02 Million | ▲ +21.6% |
| 2019 | -1.97x | $-71.79 Million | $36.49 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.